IL-7 Induced Traf1 Up-Regulation Restores HCV-Specific CD8 T Cell Reactivity in Mid-Lasting HCV Infection Featured by Presence of Directly Ex-Vivo Detectable Pentamer Binding Cells

2016 ◽  
Vol 64 (2) ◽  
pp. S511 ◽  
Author(s):  
E. Moreno-Cubero ◽  
D. Subirá ◽  
E.S. de Villalobos ◽  
J. Míquel ◽  
R. Borobia ◽  
...  
2013 ◽  
Vol 58 ◽  
pp. S143-S144
Author(s):  
J.R. Larrubia ◽  
M.U. Lokhande ◽  
S. García-Garzón ◽  
J. Miquel ◽  
A. González-Praetorious ◽  
...  

2021 ◽  
Author(s):  
Alison Tarke ◽  
John Sidney ◽  
Nils Methot ◽  
Yun Zhang ◽  
Jennifer M Dan ◽  
...  

The emergence of SARS-CoV-2 variants highlighted the need to better understand adaptive immune responses to this virus. It is important to address whether also CD4+ and CD8+ T cell responses are affected, because of the role they play in disease resolution and modulation of COVID-19 disease severity. Here we performed a comprehensive analysis of SARS-CoV-2-specific CD4+ and CD8+ T cell responses from COVID-19 convalescent subjects recognizing the ancestral strain, compared to variant lineages B.1.1.7, B.1.351, P.1, and CAL.20C as well as recipients of the Moderna (mRNA-1273) or Pfizer/BioNTech (BNT162b2) COVID-19 vaccines. Similarly, we demonstrate that the sequences of the vast majority of SARS-CoV-2 T cell epitopes are not affected by the mutations found in the variants analyzed. Overall, the results demonstrate that CD4+ and CD8+ T cell responses in convalescent COVID-19 subjects or COVID-19 mRNA vaccinees are not substantially affected by mutations found in the SARS-CoV-2 variants.


Virology ◽  
2005 ◽  
Vol 331 (1) ◽  
pp. 151-158 ◽  
Author(s):  
Felix N. Toka ◽  
Małgorzata Gieryńska ◽  
Susmit Suvas ◽  
Stephen P. Schoenberger ◽  
Barry T. Rouse

2006 ◽  
Vol 4 (6) ◽  
pp. 47
Author(s):  
A. Trojan ◽  
M. Montemurro ◽  
R.A. Stahel ◽  
D. Jäger

Author(s):  
Anastasia Gangaev ◽  
Steven L. C. Ketelaars ◽  
Sanne Patiwael ◽  
Anna Dopler ◽  
Olga I. Isaeva ◽  
...  

Abstract A large global effort is currently ongoing to develop vaccines against SARS-CoV-2, the causative agent of COVID-19. While there is accumulating evidence on the antibody response against SARS-CoV-2, little is known about the SARS-CoV-2 antigens that are targeted by CD8 T cells. To address this issue, we have analyzed samples from 20 COVID-19 patients for T cell recognition of 500 predicted MHC class I epitopes. CD8 T cell reactivity against SARS-CoV- 2 was common. Remarkably, a substantial fraction of the observed CD8 T cell responses were directed towards the ORF1ab polyprotein 1ab, and these CD8 T cell responses were frequently of a very high magnitude. The fact that a major part of the SARS-CoV-2 specific CD8 T cell response is directed against a part of the viral genome that is not included in the majority of vaccine candidates currently in development may potentially influence their clinical activity and toxicity profile.


2019 ◽  
Vol 11 (506) ◽  
pp. eaaz0302
Author(s):  
Kamila Naxerova

A new method enables large-scale identification of human T cell antigens.


Sign in / Sign up

Export Citation Format

Share Document